LDLR Variant Classification Through Activity-Normalized Prime Editing Screening

LDLR

Activity-normalized prime editing screen measuring the effect of 5,184 LDLR coding variants on LDL-cholesterol uptake

The authors developed the first activity-normalized prime editing screening pipeline, measuring the impact of 5,184 LDLR coding variants on LDL-cholesterol uptake. Each prime editing guide RNA is paired with a genotypic outcome reporter that corrects for variable editing efficiency, a key limitation of previous pooled screens. The resulting scores robustly separate pathogenic from benign ClinVar variants and show concordance with LDL-cholesterol levels in UK Biobank participants, and were calibrated to ACMG/AMP evidence strengths. Of 434 variants currently classified as uncertain, conflicting or absent from ClinVar, 322 meet thresholds for reclassification and can be prioritized for expert review. The screen also reveals a cluster of gain-of-function variants in LDLR class A repeat 5 and detects splice-altering coding variants missed by cDNA-based screens.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

This is the kind of data that genuinely unblocks reporting: 322 variants of uncertain significance become interpretable in a gene where reclassification drives lipid-lowering therapy and cascade testing. The two methodological contributions worth keeping are reporter-based normalization of editing activity and endogenous variant installation, which exposes splicing effects invisible in cDNA assays. That said, the proposed evidence strengths still need expert-panel validation before routine use, which the authors acknowledge by framing the output as prioritization for review.

Analysis by Dr Thibaut Benquey